申请人:Adir et Compagnie
公开号:US05153190A1
公开(公告)日:1992-10-06
The invention relates to pyrrolo [1,2-a] thieno [3,2-f][1,4]diazepine compounds of the formula (I) ##STR1## in which: R.sub.1 is hydrogen; alkyl optionally substituted with alkoxy, hydroxy, cycloalkyl, or phenyl; or alkyl- or arylsulfonyl; R.sub.2 is hydrogen, phenyl, or phenylalkyl; alkyl optionally substituted with hydroxyl, alkoxy, oxo, cycloalkyl or phenyl; or optionally substituted amino; R.sub.3 represents hydrogen or alkyl, and R.sub.4 and R.sub.5 independently represent: hydrogen, alkyl optionally substituted with alkoxy, cycloalkyl, or phenyl; or phenyl; their isomers, diastereoisomers and enantiomers as well as their addition salts with pharmaceutically-acceptable acids. The compounds are useful for treating cerebral ischemia, hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, and hyperglycemia and are obtained in a few steps from the corresponding substituted 2-(1-pyrrolyl)thiophenes ##STR2## Y=--CHO or H; X= CN, CONH.sub.2, CH.sub.2 NHCOR.sub.2, or CH.sub.2 NH.sub.2.
该发明涉及式(I)的吡咯并[1,2-a]噻吩[3,2-f][1,4]二氮杂环化合物##STR1##其中:R.sub.1为氢;烷基,可选地取代为烷氧基、羟基、环烷基或苯基;或烷基-或芳基磺酰基;R.sub.2为氢、苯基或苯基烷基;烷基,可选地取代为羟基、烷氧基、酮基、环烷基或苯基;或可选地取代的氨基;R.sub.3代表氢或烷基,R.sub.4和R.sub.5独立地代表:氢、烷基,可选地取代为烷氧基、环烷基或苯基;或苯基;它们的异构体、对映体和旋光异构体以及它们与药学上可接受的酸形成的加合盐。这些化合物对治疗脑缺血、高三酸甘油酯血症、高胆固醇血症、高脂血症和高血糖症有用,并可从相应取代的2-(1-吡咯基)噻吩##STR2##中经过几个步骤获得;Y=--CHO或H;X=CN、CONH.sub.2、CH.sub.2 NHCOR.sub.2或CH.sub.2 NH.sub.2。